A drug that extends life for men with advanced prostate cancer, developed at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital, has today been approved for use throughout Europe. …

Dr Simon Allen of Fine Treatment states a common belief that inflammation of a prostate may lead over time to the development of prostate cancer. Nobody can argue that infections and inflammations may represent one mechanism.…

A molecule which can stop the formation of long protein strands, known as amyloid fibrils, that cause joint pain in kidney dialysis patients has been identified by researchers at the University of Leeds. …

U.S. prostate cancer deaths have surpassed 2010s mark of 32,050 and according to reports by the National Cancer Institute, 240,890 new cases of prostate cancer have developed. An estimated one in six U.S. men will be diagnosed with it.…

African Americans are four times more likely to develop kidney failure than whites. A new study has found that a condition that occurs when the kidneys are damaged and spill protein into the urine contributes to this increased risk. …

An investigational radiopharmaceutical has been found to improve survival in patients with advanced prostate cancer in a phase 3 study that is still ongoing. Only 4 other products havemanaged to show such a survival benefit. …

Researchers on Monday released yet more evidence that early treatment of HIV in an infected heterosexual can protect his or her partner from becoming infected. The study, conducted among 1,763 couples in Africa, Asia,South America, so on.…